Resources - TD2 Precision Oncology
A Dual-specific Inhibitor of Rock/Aurk, RR-1752, for Primary Myelofibrosis - TD2 Precision Oncology
Written by
TD2 Admin
| Dec 15, 2023 5:46:00 PM
View full post